Fatal pulmonary fibrosis following 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) therapy
- 1 July 1978
Abstract
A case is reported of a child with fatal pulmonary fibrosis following BCNU therapy. This side effect has only once previously been reported with the nitrosourea group of compounds.This publication has 5 references indexed in Scilit:
- PULMONARY TOXICITY IN LONG-TERM ADMINISTRATION OF BCNU1976
- CCNU (1-[2-chloroethyl]-3-cyclohexyl-1-nitrosourea, NSC-79037) in the treatment of cancer. Phase II studyCancer, 1973
- A clinical review of bleomycin—a new antineoplastic agentCancer, 1973
- Central nervous system leukemia and solid tumors of childhood:Treatment with 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU)Cancer, 1966
- DIFFUSE INTERSTITIAL PULMONARY FIBROSIS AFTER BUSULPHAN THERAPYThe Lancet, 1963